Q3 2026 13F · SEC CIK 1213206
Marathon Capital Management
Wealth managerFiled 2026-10-23 for Q3 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $488.4M
- Reported positions
- 181
- Top holdings a year, 3 yrs
- +7.9%
- Assets under management
- $790.1M
Marathon Capital Management is a wealth manager that reported 181 positions worth $488.4M in its Q3 2026 13F, filed 2026-10-23. Its largest holdings were Price T Rowe Group Inc (TROW, 12.4%), Spdr Series Trust (BIL, 4.0%), Zeta Global Holdings Corp (ZETA, 3.1%). A portfolio copying its top holdings returned 7.9% a year over the last 3 years, against 20.4% for the S&P 500.
Marathon Capital Management holdings largest 50 of 181 positions.
Weights are shares of the filer's total reported 13F value, compared with Q2 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Marathon Capital Management bought and sold in Q3 2026, against Q2 2026.
New positions
Q2 2026's filing was too long to tell new positions apart.
Added to
- ZETA Zeta Global Holdings Corp+98.6% shares
- SGOV Ishares Tr+57.8% shares
- CALX Calix Inc+6.7% shares
Reduced
- ADMA Adma Biologics Inc-32.1% shares
Left the top 50
- MU Micron Technology Incwas 0.6%
- ENPH Enphase Energy Incwas 0.6%
- MXL Maxlinear Incwas 0.5%
Share counts compared with the Q2 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- +16.8% /yr
- S&P 500 +20.1%
- 3 years
- +7.9% /yr
- S&P 500 +20.4%
- 5 years
- -5.0% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q3 2026 | $488.4M | 181 |
| Q2 2026 | $493.9M | 187 |
| Q1 2026 | $445.2M | 171 |
| Q4 2025 | $464.7M | 171 |
| Q3 2025 | $437.0M | 163 |
| Q2 2025 | $392.0M | 163 |
| Q1 2025 | $375.5M | 158 |
| Q4 2024 | $400.1M | 154 |
| Q3 2024 | $412.5M | 154 |
| Q2 2024 | $392.4M | 145 |
| Q1 2024 | $419.1M | 154 |
| Q4 2023 | $397.8M | 153 |
Questions about Marathon Capital Management's portfolio
What stocks does Marathon Capital Management own?
Marathon Capital Management's latest 13F, for Q3 2026 and filed Oct 23, 2026, lists 181 positions worth $488.4M. The largest are Price T Rowe Group Inc (TROW) at 12.4%, Spdr Series Trust (BIL) at 4.0%, Zeta Global Holdings Corp (ZETA) at 3.1%, Amazon Com Inc (AMZN) at 2.9% and Corning Inc (GLW) at 2.9%.
What did Marathon Capital Management buy last quarter?
In Q3 2026, Marathon Capital Management added Zeta Global Holdings Corp (ZETA) (+98.6% shares), Ishares Tr (SGOV) (+57.8% shares) and Calix Inc (CALX) (+6.7% shares), compared with its Q2 2026 filing.
What did Marathon Capital Management sell last quarter?
In Q3 2026, Marathon Capital Management cut from its top 50 Micron Technology Inc (MU), cut from its top 50 Enphase Energy Inc (ENPH), cut from its top 50 Maxlinear Inc (MXL) and Adma Biologics Inc (ADMA) (-32.1% shares), compared with its Q2 2026 filing.
How has Marathon Capital Management's portfolio performed?
A portfolio copying Marathon Capital Management's 20 largest 13F holdings each quarter, from the day each filing was public, returned +7.9% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +16.8% against +20.1%. Over 5 years: -5.0% a year against +11.6%.
When is Marathon Capital Management's next 13F filing due?
13F filings are due 45 days after each quarter ends. Marathon Capital Management's filing for the quarter ending Dec 31, 2026 is due by Feb 14, 2027; this page updates the day after it is published.
How much money does Marathon Capital Management manage?
Marathon Capital Management reported $790.1M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $488.4M.